Your browser doesn't support javascript.
loading
IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes.
Asadipour, Morvarid; Fazeli, Pooria; Zohouri, Mahshid; Bemani, Peyman; Mohebbiniya, Mohsen; Khansalar, Soolmaz; Fattahi, Mohammad Reza; Kalantar, Kurosh.
Afiliação
  • Asadipour M; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Fazeli P; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Zohouri M; Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Bemani P; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Mohebbiniya M; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Khansalar S; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Fattahi MR; Gastroenterology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Kalantar K; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.
Infect Disord Drug Targets ; 21(3): 389-393, 2021.
Article em En | MEDLINE | ID: mdl-32634083
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Infect Disord Drug Targets Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite C Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Infect Disord Drug Targets Ano de publicação: 2021 Tipo de documento: Article